Lage R et al. |
Mycobacterium chelonae cutaneous infection in a patient with mixed connective tissue disease. |
|
An Bras Dermatol |
pmid:25672306
|
Pachot JI et al. |
Experimental estimation of the role of P-Glycoprotein in the pharmacokinetic behaviour of telithromycin, a novel ketolide, in comparison with roxithromycin and other macrolides using the Caco-2 cell model. |
|
J Pharm Pharm Sci |
pmid:12753725
|
Morimoto S et al. |
Chemical modification of erythromycins. I. Synthesis and antibacterial activity of 6-O-methylerythromycins A. |
1984 |
J. Antibiot. |
pmid:6706855
|
Pike VW et al. |
Semi-automated preparation of a 11C-labelled antibiotic--[N-methyl-11C]erythromycin A lactobionate. |
1984 |
Int J Appl Radiat Isot |
pmid:6231252
|
Fernandes PB et al. |
In vitro and in vivo evaluation of A-56268 (TE-031), a new macrolide. |
1986 |
Antimicrob. Agents Chemother. |
pmid:2949695
|
Segreti J et al. |
In vitro activity of A-56268 (TE-031) and four other antimicrobial agents against Chlamydia trachomatis. |
1987 |
Antimicrob. Agents Chemother. |
pmid:2952061
|
Benson CA et al. |
In vitro activity of A-56268 (TE-031), a new macrolide, compared with that of erythromycin and clindamycin against selected gram-positive and gram-negative organisms. |
1987 |
Antimicrob. Agents Chemother. |
pmid:2952063
|
Barry AL et al. |
In vitro activity of a new macrolide, A-56268, compared with that of roxithromycin, erythromycin, and clindamycin. |
1987 |
Antimicrob. Agents Chemother. |
pmid:2952064
|
Chin NX et al. |
Activity of A-56268 compared with that of erythromycin and other oral agents against aerobic and anaerobic bacteria. |
1987 |
Antimicrob. Agents Chemother. |
pmid:2953303
|
Bowie WR et al. |
In vitro activity of Ro 15-8074, Ro 19-5247, A-56268, and roxithromycin (RU 28965) against Neisseria gonorrhoeae and Chlamydia trachomatis. |
1987 |
Antimicrob. Agents Chemother. |
pmid:2953304
|
Hanson CW et al. |
Regression analysis, proposed interpretative zone size standards, and quality control guidelines for a new macrolide antimicrobial agent, A-56268 (TE-031). |
1987 |
J. Clin. Microbiol. |
pmid:2954995
|
Floyd-Reising S et al. |
In vitro activity of A-56268 (TE-031), a new macrolide antibiotic, compared with that of erythromycin and other antimicrobial agents. |
1987 |
Antimicrob. Agents Chemother. |
pmid:2955742
|
Fernandes PB et al. |
Susceptibility testing of macrolide antibiotics against Haemophilus influenzae and correlation of in vitro results with in vivo efficacy in a mouse septicemia model. |
1987 |
Antimicrob. Agents Chemother. |
pmid:2957954
|
Sasaki J et al. |
Microbial transformation of 6-O-methylerythromycin derivatives. |
1988 |
J. Antibiot. |
pmid:2971032
|
Adachi T et al. |
14-Hydroxy-6-O-methylerythromycins A, active metabolites of 6-O-methylerythromycin A in human. |
1988 |
J. Antibiot. |
pmid:2971033
|
Waites KB et al. |
In vitro susceptibilities of mycoplasmas and ureaplasmas to new macrolides and aryl-fluoroquinolones. |
1988 |
Antimicrob. Agents Chemother. |
pmid:2973283
|
Barry AL et al. |
Variability of clarithromycin and erythromycin susceptibility tests with Haemophilus influenzae in four different broth media and correlation with the standard disk diffusion test. |
1988 |
J. Clin. Microbiol. |
pmid:2976773
|
Chang HR and Pechère JC |
In vitro effects of four macrolides (roxithromycin, spiramycin, azithromycin [CP-62,993], and A-56268) on Toxoplasma gondii. |
1988 |
Antimicrob. Agents Chemother. |
pmid:2837140
|
Barry AL et al. |
In vitro activities of azithromycin (CP 62,993), clarithromycin (A-56268; TE-031), erythromycin, roxithromycin, and clindamycin. |
1988 |
Antimicrob. Agents Chemother. |
pmid:2840016
|
Adachi T et al. |
Crystal and molecular structure of (14R)-14-hydroxy-6-O-methylerythromycin A. |
1989 |
J. Antibiot. |
pmid:2737946
|
Gorzynski EA et al. |
Comparative antimycobacterial activities of difloxacin, temafloxacin, enoxacin, pefloxacin, reference fluoroquinolones, and a new macrolide, clarithromycin. |
1989 |
Antimicrob. Agents Chemother. |
pmid:2524998
|
Fernandes PB et al. |
New macrolides active against Streptococcus pyogenes with inducible or constitutive type of macrolide-lincosamide-streptogramin B resistance. |
1989 |
Antimicrob. Agents Chemother. |
pmid:2523688
|
Fernandes PB et al. |
In vitro and in vivo activities of clarithromycin against Mycobacterium avium. |
1989 |
Antimicrob. Agents Chemother. |
pmid:2530933
|
Kohno Y et al. |
Comparative pharmacokinetics of clarithromycin (TE-031), a new macrolide antibiotic, and erythromycin in rats. |
1989 |
Antimicrob. Agents Chemother. |
pmid:2526615
|
Tinel M et al. |
Effects of clarithromycin on cytochrome P-450. Comparison with other macrolides. |
1989 |
J. Pharmacol. Exp. Ther. |
pmid:2527301
|
Adachi T et al. |
Hydroxylation and N-demethylation of clarithromycin (6-O-methylerythromycin A) by Mucor circinelloides. |
1989 |
J. Antibiot. |
pmid:2529234
|
Naik S and Ruck R |
In vitro activities of several new macrolide antibiotics against Mycobacterium avium complex. |
1989 |
Antimicrob. Agents Chemother. |
pmid:2817858
|
Faghih R et al. |
Synthesis and antibacterial activity of (9S)-9-dihydroclarithromycin. |
1990 |
J. Antibiot. |
pmid:2147921
|
Perronne C et al. |
Activities of clarithromycin, sulfisoxazole, and rifabutin against Mycobacterium avium complex multiplication within human macrophages. |
1990 |
Antimicrob. Agents Chemother. |
pmid:2171421
|
Morimoto S et al. |
Chemical modification of erythromycins. III. In vitro and in vivo antibacterial activities of new semisynthetic 6-O-methylerythromycins A, TE-031 (clarithromycin) and TE-032. |
1990 |
J. Antibiot. |
pmid:2139023
|
Kohno Y et al. |
Autobacteriographic studies of clarithromycin and erythromycin in mice. |
1990 |
Antimicrob. Agents Chemother. |
pmid:2140497
|
Marchi E |
Comparative efficacy and tolerability of clarithromycin and amoxycillin in the treatment of out-patients with acute maxillary sinusitis. |
1990 |
Curr Med Res Opin |
pmid:2140546
|
Scaglione F |
Comparison of the clinical and bacteriological efficacy of clarithromycin and erythromycin in the treatment of streptococcal pharyngitis. |
1990 |
Curr Med Res Opin |
pmid:2140547
|
Morimoto S et al. |
Chemical modification of erythromycins. VI. Structure and antibacterial activity of acid degradation products of 6-O-methylerythromycins A. |
1990 |
J. Antibiot. |
pmid:2141599
|
Hardy DJ et al. |
Enhancement of the in vitro and in vivo activities of clarithromycin against Haemophilus influenzae by 14-hydroxy-clarithromycin, its major metabolite in humans. |
1990 |
Antimicrob. Agents Chemother. |
pmid:2143642
|
Cacciapuoti AF et al. |
Microbiological and pharmacokinetic studies of acyl demycinosyltylosin and related tylosin derivatives. |
1990 |
J. Antibiot. |
pmid:2145254
|
Ferrero JL et al. |
Metabolism and disposition of clarithromycin in man. |
1990 Jul-Aug |
Drug Metab. Dispos. |
pmid:1976065
|
Straneo G and Scarpazza G |
Efficacy and safety of clarithromycin versus josamycin in the treatment of hospitalized patients with bacterial pneumonia. |
1990 Mar-Apr |
J. Int. Med. Res. |
pmid:2140330
|
Fraschini F |
Clinical efficacy and tolerance of two new macrolides, clarithromycin and josamycin, in the treatment of patients with acute exacerbations of chronic bronchitis. |
1990 Mar-Apr |
J. Int. Med. Res. |
pmid:2140331
|
Anderson G |
Clarithromycin in the treatment of community-acquired lower respiratory tract infections. |
1991 |
J. Hosp. Infect. |
pmid:1684979
|
Davey PG |
The pharmacokinetics of clarithromycin and its 14-OH metabolite. |
1991 |
J. Hosp. Infect. |
pmid:1684980
|
King A and Phillips I |
A comparison of the in-vitro activity of clarithromycin, a new macrolide antibiotic, with erythromycin and other oral agents. |
1991 |
J. Hosp. Infect. |
pmid:1684981
|
Wood MJ |
The tolerance and toxicity of clarithromycin. |
1991 |
J. Hosp. Infect. |
pmid:1684982
|
|
Clarithro- and azithromycin--better erythromycins? |
1991 |
Drug Ther Bull |
pmid:1665125
|
Rastogi N et al. |
Antimycobacterial spectrum of sparfloxacin and its activities alone and in association with other drugs against Mycobacterium avium complex growing extracellularly and intracellularly in murine and human macrophages. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1667250
|
Gu JW et al. |
Bactericidal activity of clarithromycin and its 14-hydroxy metabolite against Haemophilus influenzae and streptococcal pathogens. |
1991 |
J Clin Pharmacol |
pmid:1837032
|
Hughes WT and Killmar JT |
Synergistic anti-Pneumocystis carinii effects of erythromycin and sulfisoxazole. |
1991 |
J. Acquir. Immune Defic. Syndr. |
pmid:2016690
|
Rastogi N and Labrousse V |
Extracellular and intracellular activities of clarithromycin used alone and in association with ethambutol and rifampin against Mycobacterium avium complex. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1828135
|
Ji B et al. |
Effectiveness of clarithromycin and minocycline alone and in combination against experimental Mycobacterium leprae infection in mice. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1828136
|
Lu MY et al. |
A polymer carrier system for taste masking of macrolide antibiotics. |
1991 |
Pharm. Res. |
pmid:1829521
|
Perronne C et al. |
Activities of sparfloxacin, azithromycin, temafloxacin, and rifapentine compared with that of clarithromycin against multiplication of Mycobacterium avium complex within human macrophages. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1656860
|
Morgan DK et al. |
A reversed-phase high-performance liquid chromatographic method for the determination and identification of clarithromycin as the drug substance and in various dosage forms. |
1991 |
J Pharm Biomed Anal |
pmid:1831386
|
Dautzenberg B et al. |
Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome. A controlled clinical trial. |
1991 |
Am. Rev. Respir. Dis. |
pmid:1832527
|
Rotsch TD et al. |
Determination of clarithromycin as a contaminant on surfaces by high-performance liquid chromatography using electrochemical detection. |
1991 |
Pharm. Res. |
pmid:1833731
|
Jorgensen JH et al. |
Activity of clarithromycin and its principal human metabolite against Haemophilus influenzae. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1834012
|
Truffot-Pernot C et al. |
Effect of pH on the in vitro potency of clarithromycin against Mycobacterium avium complex. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1834015
|
Hamedani P et al. |
The safety and efficacy of clarithromycin in patients with Legionella pneumonia. |
1991 |
Chest |
pmid:1835689
|
Fernandez-Martin J et al. |
Pyrimethamine-clarithromycin combination for therapy of acute Toxoplasma encephalitis in patients with AIDS. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1836943
|
Gelber RH et al. |
Activities of various macrolide antibiotics against Mycobacterium leprae infection in mice. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1648889
|
Cogo R et al. |
[Dynamics of sIgA concentration in bronchial secretions in patients with COBP treated with clarithromycin]. |
1991 Jan-Dec |
G Ital Chemioter |
pmid:1365564
|
De Punzio C et al. |
Isolation of Chlamydia trachomatis during IVF-ET. |
1991 Jul-Aug |
Acta Eur. Fertil. |
pmid:1844324
|
Rehg JE |
Anti-cryptosporidial activity of macrolides in immunosuppressed rats. |
1991 Nov-Dec |
J. Protozool. |
pmid:1667930
|
Hughes WT |
Macrolide-antifol synergism in anti-Pneumocystis carinii therapeutics. |
1991 Nov-Dec |
J. Protozool. |
pmid:1818149
|
Logan RP et al. |
Clarithromycin and omeprazole for Helicobacter pylori. |
1992 |
Lancet |
pmid:1353155
|
Hammerschlag MR et al. |
In vitro activities of azithromycin, clarithromycin, L-ofloxacin, and other antibiotics against Chlamydia pneumoniae. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1324650
|
Paulsen P et al. |
Influence of azithromycin and other macrolides on the intracellular killing of Staphylococcus aureus by human polymorphonuclear leucocytes of healthy donors and a patient with Chédiak-Higashi syndrome. |
1992 |
Chemotherapy |
pmid:1324831
|
Heifets LB et al. |
Clarithromycin minimal inhibitory and bactericidal concentrations against Mycobacterium avium. |
1992 |
Am. Rev. Respir. Dis. |
pmid:1532486
|
Cynamon MH and Klemens SP |
Activity of azithromycin against Mycobacterium avium infection in beige mice. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1329622
|
Ruf B et al. |
Acquired resistance of MAI to clarithromycin. |
1992 |
Am. Rev. Respir. Dis. |
pmid:1533999
|
Chonmaitree T et al. |
Effect of viral respiratory tract infection on outcome of acute otitis media. |
1992 |
J. Pediatr. |
pmid:1534364
|
Knothe H |
[Short-term therapy of acute respiratory and ORL infections with Clarithromycin]. |
1992 |
Z Gesamte Inn Med |
pmid:9022402
|
Bale MJ et al. |
MIC quality control guidelines for Haemophilus susceptibility tests using cefdinir (FK482), cefepime, cefetamet, cefpirome, ceftibuten, fleroxacin, temafloxacin, clarithromycin, RP59500, and trospectomycin. |
1992 |
J. Clin. Microbiol. |
pmid:1310329
|
Neu HC |
New macrolide antibiotics: azithromycin and clarithromycin. |
1992 |
Ann. Intern. Med. |
pmid:1310839
|
Bahal N and Nahata MC |
The new macrolide antibiotics: azithromycin, clarithromycin, dirithromycin, and roxithromycin. |
1992 |
Ann Pharmacother |
pmid:1318761
|
Berk SL |
New macrolide antibiotics. |
1992 |
Ann. Intern. Med. |
pmid:1386966
|
Chu SY et al. |
Absolute bioavailability of clarithromycin after oral administration in humans. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1387301
|
Yajko DM et al. |
Comparison of the intracellular activities of clarithromycin and erythromycin against Mycobacterium avium complex strains in J774 cells and in alveolar macrophages from human immunodeficiency virus type 1-infected individuals. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1387302
|
de Lalla F et al. |
Clarithromycin-ciprofloxacin-amikacin for therapy of Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1387303
|
Cohen Y et al. |
Activities of WIN-57273, minocycline, clarithromycin, and 14-hydroxy-clarithromycin against Mycobacterium avium complex in human macrophages. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1332586
|
Sifrim D et al. |
Comparison of the effects of midecamycin acetate and clarithromycin on gastrointestinal motility in man. |
1992 |
Drugs Exp Clin Res |
pmid:1292916
|
Dautzenberg B |
[Treatment of atypical mycobacterium infections: current state and therapeutic perspectives]. |
1992 |
Rev Pneumol Clin |
pmid:1296257
|
Peters DH and Clissold SP |
Clarithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential. |
1992 |
Drugs |
pmid:1379907
|
Calzolari E et al. |
The efficacy of clarythromycin (A-56268, TE-031) in the treatment of genital chlamydial infection. |
1992 |
Drugs Exp Clin Res |
pmid:1306155
|
Klemens SP et al. |
Activity of clarithromycin against Mycobacterium avium complex infection in beige mice. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1336945
|
Ji B et al. |
Bactericidal activities of single or multiple doses of various combinations of new antileprosy drugs and/or rifampin against M. leprae in mice. |
1992 |
Int. J. Lepr. Other Mycobact. Dis. |
pmid:1338596
|
Yajko DM |
In vitro activity of antimicrobial agents against the Mycobacterium avium complex inside macrophages from HIV1-infected individuals: the link to clinical response to treatment? |
1992 |
Res. Microbiol. |
pmid:1455069
|
Omura S et al. |
[Research and development of clarithromycin]. |
1992 |
Yakugaku Zasshi |
pmid:1469609
|
Chu SY et al. |
Clarithromycin pharmacokinetics in healthy young and elderly volunteers. |
1992 |
J Clin Pharmacol |
pmid:1474166
|
Gelber RH et al. |
Clarithromycin at very low levels and on intermittent administration inhibits the growth of M. leprae in mice. |
1992 |
Int. J. Lepr. Other Mycobact. Dis. |
pmid:1474290
|
Heifets LB et al. |
Bacteriostatic and bactericidal activities of gentamicin alone and in combination with clarithromycin against Mycobacterium avium. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1416852
|
Brown BA et al. |
Activities of clarithromycin against eight slowly growing species of nontuberculous mycobacteria, determined by using a broth microdilution MIC system. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1416891
|
Biehle J and Cavalieri SJ |
In vitro susceptibility of Mycobacterium kansasii to clarithromycin. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1416897
|
Sturgill MG and Rapp RP |
Clarithromycin: review of a new macrolide antibiotic with improved microbiologic spectrum and favorable pharmacokinetic and adverse effect profiles. |
1992 |
Ann Pharmacother |
pmid:1421677
|
Schrock CG |
Clarithromycin vs penicillin in the treatment of streptococcal pharyngitis. |
1992 |
J Fam Pract |
pmid:1453146
|
Chaisson R |
Clarithromycin is effective against M. avium complex in AIDS. |
1992 |
Am Fam Physician |
pmid:1456199
|
Ji B et al. |
Selection of resistant mutants of Mycobacterium avium in beige mice by clarithromycin monotherapy. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1482155
|
Rastogi N and Goh KS |
Effect of pH on radiometric MICs of clarithromycin against 18 species of mycobacteria. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1482156
|
Rastogi N et al. |
Activity of clarithromycin compared with those of other drugs against Mycobacterium paratuberculosis and further enhancement of its extracellular and intracellular activities by ethambutol. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1482157
|
Derouin F et al. |
Synergistic activity of clarithromycin and minocycline in an animal model of acute experimental toxoplasmosis. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1482160
|
Takeda H et al. |
[A study to clarify the mechanism of the usefulness of the macrolides--the influence of clarithromycin to biofilm with P. aeruginosa]. |
1992 |
Kansenshogaku Zasshi |
pmid:1363435
|